Replies to post #215661 on Biotech Values

[Nateej2001]

With that in mind, are you, and others holding?

I’ve sold 6,000 shares of what was 19,000; unfortunately 3,000 of which I sold last week. I got a little scared going into results as I’ve had too many go the other way.

[DewDiligence]

RVNC—Most phase-3 results seem to underperform versus phase-2.

This is an exception for the reason mentioned in #msg-134851079.

The stock price is still under where it peaked following Belmont. I would have expected a slightly bigger jump on this solid result today.

The proper comparison is between the pair of enterprise values rather than the share prices; there are more shares outstanding now than there were immediately following the BELMONT (phase-2) data.